Dr. Haitham Shaheen | Oncology Awards | Best Researcher Award

Posted on by Global Sensor Awards

Dr. Haitham Shaheen | Oncology Awards | Best Researcher Award 

Dr. Haitham Shaheen, Swansea bay university health board, United Kingdom

Dr. Haitham Shaheen is a highly accomplished medical oncology consultant with a distinguished academic and clinical background in oncology. Born on September 30, 1987, he currently serves as a Consultant in Medical Oncology at Somerset NHS Foundation Trust, UK, where he independently manages cancer patients, prescribes systemic anticancer therapies (SACT), and actively participates in multidisciplinary teams (MDTs). Previously, he held academic and clinical positions at Suez Canal University Hospital in Egypt, advancing from Assistant Lecturer to Consultant and Lecturer of Clinical Oncology. He holds an MD in Clinical Oncology, MRCP-UK, and certification from the European Society of Medical Oncology (ESMO). Dr. Shaheen has authored multiple high-impact publications on prostate cancer, pediatric lymphoma, and radiotherapy, and has presented his research internationally. A certified expert educator and active contributor to medical education and hospital training programs, he also held leadership roles in radiotherapy and digital transformation initiatives. His dedication to oncology, both clinically and academically, has earned him recognition for his contributions to research, education, and patient care.

Professional Profile:

SCOPUS

Summary of Suitability: Dr. Haitham Shaheen – Research for Best Researcher Award

Dr. Haitham Shaheen is a highly accomplished clinical oncologist and researcher whose work demonstrates a strong blend of academic rigor, clinical excellence, and impactful research in oncology. With dual MD degrees in Clinical Oncology, MRCP-UK, and ESMO certification, he possesses an exceptional academic foundation. His recent publications in high-impact journals such as Brachytherapy and the International Journal of Radiation Oncology, Biology, Physics reflect his deep engagement with evidence-based cancer treatment and translational research. Dr. Shaheen’s focus on prostate cancer outcomes and innovative treatment safety showcases a commitment to improving oncological care through research. In his current role as a consultant at the Somerset NHS Foundation Trust, he continues to integrate clinical practice with research, underscoring his suitability for the Best Researcher Award.

🎓 Education

  • 🩺 Bachelor of Medicine and Surgery – Suez Canal University, Egypt (Nov 2010)

  • 📘 MD in Clinical Oncology – Suez Canal University (March 2016)

  • 🎓 MD (Highest Academic Medical Degree in Egypt) – Suez Canal University (March 2021)

  • 🇬🇧 MRCP (UK) – Royal College of Physicians (Jan 2022)

  • 🌍 ESMO Certificate – European Society of Medical Oncology (Nov 2022)

💼 Work Experience

  • 👨‍⚕️ Consultant, Medical Oncology – Somerset NHS Foundation Trust, UK (Sep 2023 – Present)

  • 👨‍🏫 Lecturer & Consultant, Clinical Oncology – Suez Canal University Hospital, Egypt (Mar 2021 – Sep 2023)

  • 🧑‍⚕️ Assistant Lecturer & Specialist, Clinical Oncology – Suez Canal University Hospital (Mar 2016 – Mar 2021)

  • 🏥 Resident, Clinical Oncology – Suez Canal University Hospital (2012 – 2016)

  • 🩺 Internship – Suez Canal University Hospital (2011 – 2012)

🏆 Achievements, Awards & Publications

  • 📝 First Author –

    • Voluntary DIBH with VMAT in Pediatric Hodgkin’s Lymphoma, Future Oncology Journal (Jan 2023)

    • Systematic Review on Prostate Cancer Outcomes, IJROBP (Red Journal) (Oct 2023)

  • 🤝 Co-author –

    • Safety of HDR Brachytherapy in Prostate Cancer, Brachytherapy Journal (Dec 2023)

    • Oncologist Perceptions on Cancer Patient Vaccination, IJCBR (Mar 2022)

    • Pediatric Radiotherapy Utilization Rate, Radiotherapy and Oncology (2021)

  • 🎤 Oral Presentations on VMAT and DIBH in Mediastinal Lymphoma

  • 📅 Conference Organizer & Secretary – 1st and 2nd Oncology Conferences, Suez Canal University (2018, 2019)

Publication Top Notes:

Safety of high-dose rate (HDR) brachytherapy for patients with prostate cancer and history of prior chemoradiation for rectal cancer: A case series

Prof. Dr. Maria Luisa Brandi | Biomolecular Diagnosis Awards | Excellence in Research Award

Posted on by Global Sensor Awards

Prof. Dr. Maria Luisa Brandi | Biomolecular Diagnosis Awards | Excellence in Research Award 

Prof. Dr. Maria Luisa Brandi, FIRMO Foundation, Italy

Maria Luisa Brandi is a Full Professor of Endocrinology at the University of Florence Medical School in Italy. She earned her MD from the University of Florence in 1977 and later completed a Ph.D. in Cell Biology from the University of Rome. Her distinguished academic career includes a tenure as Visiting Scientist at the NIH (USA) and leadership of multiple clinical and research units, notably on hereditary endocrine tumors and metabolic bone disorders. With over 600 peer-reviewed publications and 250 book chapters, her research spans osteoporosis, parathyroid disorders, bone genetics, and rare metabolic diseases. She has served on editorial boards of major journals and held prestigious positions in global endocrine and osteoporosis societies. As the President of the F.I.R.M.O. Foundation, she also champions public awareness and research funding for bone diseases. Her accolades include the Helena Rubinstein “Women in Science” Award and the Pierre Delmas Prize. She is widely recognized as one of Italy’s leading scientists in endocrinology and bone research.

Professional Profile:

ORCID

SCOPUS

Summary of Suitability for Excellence in Research Award – Maria Luisa Brandi

Professor Maria Luisa Brandi is a world-renowned expert in endocrinology with a distinguished academic and research career spanning over four decades. As a Full Professor of Endocrinology at the University of Florence and Director of multiple clinical and research units, she has made pioneering contributions to the fields of metabolic bone diseases, hereditary endocrine tumors, and rare bone disorders.

🎓 Education

  • MD in Medicine – University of Florence, Italy (1977)

  • Specialization in Endocrinology – University of Florence Hospital (1977–1980)

  • Ph.D. in Cell Biology – University of Rome (1988)

  • 🧬 Postdoctoral Research (Visiting Scientist) – NIH, USA (1984–1990)

🧪 Work Experience

  • Professor of Endocrinology – University of Florence (Assistant → Associate → Full Professor, 1990–Present)

  • Director –

    • Regional Center on Hereditary Endocrine Tumors (1998–Present)

    • Clinical Unit on Metabolic Bone Disorders (2007–Present)

    • University Master in Metabolic Bone Disease (2004–Present)

  • Scientific Roles –

    • Delegate for Italy-USA Academic Interactions (2000–2003)

    • Scientific Attaché for the City of Florence (2015–Present)

    • Health Education Delegate, University of Florence (2016–Present)

  • President – F.I.R.M.O. Foundation (2006–Present) 🦴

  • Editorial Work – Editor-in-Chief, Clinical Cases in Bone and Mineral Metabolism (2004–Present)

🏆 Awards & Honors

  • 🧪 Roussel Italia Award (1988)

  • 🌍 European Foundation Award (1989)

  • 🧫 Schering Award, Italian Endocrine Society (1990)

  • 👵 Sandoz Foundation Award for Gerontological Research (1991)

  • 👩‍🔬 Helena Rubinstein “Women in Science” Award (1998)

  • 🧠 Italian Endocrine Society Senior Award (2003)

  • 💎 Pierre Delmas IOF/ESCEO Prize (2013)

  • 🇮🇹 Top Italian Scientist Recognition (2016)

📚 Publications & Research

  • 📝 600+ peer-reviewed papers

  • 📘 250 book chapters and books

  • 💡 Research Areas:

    • Genetics & Clinics of Osteoporosis

    • Parathyroid Disorders

    • Bone Cell Biology

    • Endocrine Neoplasia

    • Epidemiology & Rare Bone Diseases

Publication Top Notes:

Serums miR-24-3p and miR-1301-3p as Potential Biomarkers in MEN1 Syndrome

Antiproliferative Role of Natural and Semi-Synthetic Tocopherols on Colorectal Cancer Cells Overexpressing the Estrogen Receptor β

Establishment and Molecular Characterization of a Human Stem Cell Line from a Primary Cell Culture Obtained from an Ectopic Calcified Lesion of a Tumoral Calcinosis Patient Carrying a Novel <i>GALNT3</i> Mutation

The Presence of the Endocannabinoid System in an In Vitro Model of Gorham-Stout Disease and Its Possible Role in the Pathogenesis

Up-to-Date Imaging for Parathyroid Tumor Localization in MEN1 Patients with Primary Hyperparathyroidism: When and Which Ones (A Narrative Pictorial Review)

Mechanisms of Action of Phytoestrogens and Their Role in Familial Adenomatous Polyposis

Role of Nutrition in the Management of Patients with Multiple Endocrine Neoplasia Type 1

Irisin and Its Role in Postmenopausal Osteoporosis and Sarcopenia